360 related articles for article (PubMed ID: 21111321)
1. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
Balzli CL; Caballero AR; Tang A; Weeks AC; O'Callaghan RJ
J Cataract Refract Surg; 2010 Dec; 36(12):2160-7. PubMed ID: 21111321
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME
J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
[TBL] [Abstract][Full Text] [Related]
5. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
Donnenfeld ED; Comstock TL; Proksch JW
J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
[TBL] [Abstract][Full Text] [Related]
6. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
[TBL] [Abstract][Full Text] [Related]
7. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
8. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
Yoshida J; Kim A; Pratzer KA; Stark WJ
J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
[TBL] [Abstract][Full Text] [Related]
10. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
Harper T; Miller D; Flynn HW
Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro susceptibility of besifloxacin and seven comparators against ciprofloxacin- and methicillin-susceptible/nonsusceptible staphylococci.
Miller D; Chang JS; Flynn HW; Alfonso EC
J Ocul Pharmacol Ther; 2013 Apr; 29(3):339-44. PubMed ID: 23289847
[TBL] [Abstract][Full Text] [Related]
12. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
13. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
[TBL] [Abstract][Full Text] [Related]
14. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
[TBL] [Abstract][Full Text] [Related]
15. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
[TBL] [Abstract][Full Text] [Related]
16. The effect of cataract surgery on ocular levels of topical moxifloxacin.
Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes.
Major JC; Engelbert M; Flynn HW; Miller D; Smiddy WE; Davis JL
Am J Ophthalmol; 2010 Feb; 149(2):278-283.e1. PubMed ID: 19926069
[TBL] [Abstract][Full Text] [Related]
18. Besifloxacin ophthalmic suspension 0.6%.
Carter NJ; Scott LJ
Drugs; 2010; 70(1):83-97. PubMed ID: 20030427
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
20. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
